Table 1. Patient demographics and baseline disease characteristics.
| |
Patients (N=21) |
|
|---|---|---|
| Parameter | Number | % |
|
Age, years | ||
| <65 | 17 | 81.0 |
| ⩾65 |
4 |
19.0 |
|
Sex | ||
| Male | 14 | 66.7 |
| Female |
7 |
33.3 |
|
ECOG performance status | ||
| 0 | 15 | 71.4 |
| 1 |
6 |
28.6 |
|
Cancer type | ||
| Melanoma | 17 | 81.0 |
| Stage IV M1a | 2 | 9.5 |
| Stage IV M1b | 6 | 28.6 |
| Stage IV M1c | 9 | 42.9 |
| Mesothelioma, stage IV | 1 | 4.8 |
| Prostate cancer, stage IV | 1 | 4.8 |
| Non-small cell lung cancer, stage IV | 1 | 4.8 |
| Pancreatic cancer, stage IV |
1 |
4.8 |
|
Prior therapy | ||
| Surgery | 18 | 85.7 |
| Systemic therapy | 13 | 61.9 |
| Number of regimens | ||
| 1 | 11 | 52.4 |
| 2 | 1 | 4.8 |
| 3 | 1 | 4.8 |
| Radiation therapy | 5 | 23.8 |
Abbreviation: ECOG=Eastern cooperative oncology group.